The importance of planning for a seamless transition in an adaptive phase II randomised trial
Main Authors: | Marshall Andrea, Dunn Janet A, Fletcher Julie, Higgins Helen B, Poole Christopher J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Trials |
Similar Items
-
An Adaptive Seamless Phase II/III Design for Binary Endpoints in Clinical Trials
by: Yuan, Ming-Jun, et al.
Published: (2012) -
Dose selection in seamless phase II/III clinical trials based on efficacy and toxicity
by: Kimani, Peter Kung'u
Published: (2009) -
Single‐phase wind‐BES microgrid with seamless transition capability
by: Tripurari Nath Gupta, et al.
Published: (2021-02-01) -
A novel Bayesian seamless phase I/II design.
by: Haitao Pan, et al.
Published: (2013-01-01) -
An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
by: Stallard Nigel
Published: (2011-12-01)